2016 Dec;27(8):640-648.

Lee MR1, Weerts EM1b

Vaega o Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, Bethesda bDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

lē faʻatino

O loʻo faʻateleina le fiafia i le faʻaaogaina o le oxytocin (OT) o se faʻafitauli e ono togafitia mo le ava malosi ma isi faʻafitauli o loʻo faʻaaoga. OT o se neuropeptide e faʻatonutonu ai fetuʻutuʻunaʻi gaioiga e fesoʻotaʻi ma vaisu e aofia ai le taui, faʻapalepale, faʻafesoʻotaʻi aʻoaʻoga, manatua, ma tali atu faʻanoanoa. OT galueaina ona aafiaga e ala i fegalegaleaiga ma le hypothalamic-pituitary-adrenal axis ma le tele o neurotransmitter polokalama e aofia ai le dopamine mesolimbic taui ma corticotrophin-faamatuu mafuaʻaga popole vaega. E maualuga le fiafia i aʻafiaga o OT i faʻafitauli o le mafaufau, ona o le malosi o le fesoʻotaʻiga i le va o le faʻafitauli, vailaʻau ma le toe foʻi mai, ma le iloa o le faʻatonutonuina o gaioiga hypothalamic-pituitary-adrenal e fesoʻotaʻi ma faʻafitauli o vailaʻau. I le taimi lava lea e tasi, o le OT system e fesuiaʻiina e ala i le tigaina poʻo le faʻaletonu o vailaau. O lenei toe iloiloga otooto mai ai le muamua ma le aʻoaʻoga o tusitusiga i luga o le OT system ma lona faʻatatau i vailaau faʻasaina ma le tagofia oona. I se faʻaopopoga, o faʻamaumauga mai faʻataʻitaʻiga lata mai faʻataʻitaʻiga na faʻatino i tagata auai ma le kokain, cannabis, poʻo le ava malosi faʻaaogaina ua aofia ai ma faʻamaoniga o le OT e mafai ona fesoasoani e faʻaleleia ai le tali atu o le mafaufau ma le mafaufau, ma faʻaititia le faʻafitauli o le hypercortisolism, le lelei lagona, ma le aveeseina o auga.